CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness

Part of paid clinical trials in Waltham, Massachusetts.

Sponsor
CorEvitas
Study ID
NCT04504955
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Observational Non-Interventional Registry — OTHER
    Observational Non-Interventional Registry

Study Details

This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for patients with atopic dermatitis under the care of a licensed dermatologist or qualified physician extender. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices. Condition or disease : Atopic Dermatitis

Key Dates

Start date
Jul 14, 2020
Status verified
Jan 2026
Primary completion
Dec 31, 2100
Completion
Dec 31, 2100

Study Design

Enrollment
10,000 participants (estimated)

Arms

  • Arm: Atopic Dermatitis
    Pts presenting to enrolling sites across in North America and select European countries are invited to enroll if eligible

Primary Outcome Measure

AD epidemiology, presentation, natural history, management, and outcomes [ Time Frame: Through Study completion, an average of 10years ]

Locations (1)

FacilityCityStateZIPSite coordinators
CorEvitas, LLCWalthamMassachusetts02451-

Find similar trials in Waltham, MA

By condition
Atopic dermatitis / eczema
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
CorEvitas, LLC· Waltham, MA

Related Studies